Annual Drug Patent Expirations for ENTRESTO
Entresto is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
Drug patent litigation for ENTRESTO.
This drug has thirty-six patent family members in twenty-seven countries.
The generic ingredient in ENTRESTO is sacubitril; valsartan. One supplier is listed for this compound. Additional details are available on the sacubitril; valsartan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
